Vicor (VICR) director sells 1,216 shares and receives new option grant
Rhea-AI Filing Summary
Vicor Corp director Andrew D'Amico reported a mix of option activity and share sales. On June 22, 2026, he exercised 1,216 shares of common stock through a non-qualified stock option at an exercise price of $32.89 per share, then sold the same 1,216 shares of common stock in multiple open-market transactions at weighted average prices between $354.12 and $367.10.
The filing states these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2024, indicating the timing was planned in advance. Following the transactions, he reported holding no common stock directly. He also received a new grant of 548 non-qualified stock options with an exercise price of $365.53 per share, expiring on June 22, 2036, which vest over a five-year period under Vicor’s Amended and Restated 2000 Stock Option and Incentive Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 1,216 shares ($399K approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
D'Amico Andrew
Role
Director
Sold
1,216 shs ($439K)
Approx. gross sale proceeds
$439K
Approx. exercise cost
$40K
Approx. pre-tax spread
$399K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 548 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 1,216 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,216 | $32.89 | $40K |
| Sale | Common Stock | 100 | $354.12 | $35K |
| Sale | Common Stock | 300 | $357.47 | $107K |
| Sale | Common Stock | 200 | $359.05 | $72K |
| Sale | Common Stock | 200 | $362.13 | $72K |
| Sale | Common Stock | 200 | $363.33 | $73K |
| Sale | Common Stock | 116 | $365.8372 | $42K |
| Sale | Common Stock | 100 | $367.10 | $37K |
Holdings After Transaction:
Non Qualified Stock Option — 4,196 shares (Direct);
Common Stock — 0 shares (Direct)
Footnotes (9)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.1200 to $354.1200
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.4100 to $357.5200
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.9100 to $359.1900
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.0800 to $362.1800
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.3000 to $363.3600
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.8000 to $366.0700
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.1000 to $367.1000
- F9. Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026 and vest over a five year period.
Key Figures
Shares sold: 1,216 shares
Sale price range: $354.12–$367.10 per share
Options exercised: 1,216 shares at $32.89/share
+5 more
8 metrics
Shares sold
1,216 shares
Common stock sold in open-market transactions on June 22, 2026
Sale price range
$354.12–$367.10 per share
Weighted average price ranges across multiple sale transactions
Options exercised
1,216 shares at $32.89/share
Non-qualified stock option exercise into common stock
New option grant size
548 options
Non-qualified stock option grant on June 22, 2026
New option exercise price
$365.53 per share
Exercise price of 548 newly granted options
New option expiration
June 22, 2036
Expiration date of newly granted non-qualified stock options
Common shares after
0 shares
Directly held Vicor common stock following reported transactions
Rule 10b5-1 plan adoption date
September 12, 2024
Date the pre-arranged trading plan was adopted
Key Terms
Rule 10b5-1 trading plan, Non Qualified Stock Option, weighted average price, Amended and Restated 2000 Stock Option and Incentive Plan, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non Qualified Stock Option financial
"security_title: Non Qualified Stock Option"
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Amended and Restated 2000 Stock Option and Incentive Plan financial
"Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026"
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion"
FAQ
What did Vicor (VICR) director Andrew D'Amico report in this Form 4?
Andrew D'Amico reported exercising options for 1,216 Vicor common shares and selling 1,216 shares in open-market trades. He also received a new grant of 548 non-qualified stock options that vest over five years under the company’s stock option and incentive plan.
What option exercise did Andrew D'Amico report for Vicor (VICR)?
He exercised a non-qualified stock option covering 1,216 Vicor common shares at an exercise price of $32.89 per share. This derivative exercise converted the option into common stock, which was then sold in the same filing’s reported open-market transactions.
What new stock options did Andrew D'Amico receive from Vicor (VICR)?
He received a grant of 548 non-qualified stock options with an exercise price of $365.53 per share, expiring June 22, 2036. The footnotes specify these options were granted under Vicor’s Amended and Restated 2000 Stock Option and Incentive Plan and vest over five years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
